Understanding immediate non-IgE drug hypersensitivity reactions (MIND-HR)
Official title: Mechanisms of Immediate Non-IgE-mediated Drug Hypersensitivity Reactions (MIND-HR)
Funded at Ut Southwestern Medical Center · NIH-11550126 · Data updated 2026-11-12
A patient-focused program aims to improve how doctors diagnose and manage rapid allergic-like reactions to drugs, especially antibiotics, by studying the mechanisms and biomarkers involved.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | July 23, 2025 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $101,217 |
| NIH project number | 3UG3AI190386-02S1 |
| Project ID | NIH-11550126 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients who experience immediate drug reactions that are not mediated by IgE, particularly those related to antibiotics or other charged drugs.
✕Less likely to help
Patients without a history of non-IgE-mediated drug reactions are not the target of this study.
What this research studies
This research will work across multiple clinical sites to validate tests and biomarkers that help identify non-IgE drug reactions. It builds on existing work that links certain skin cells and receptors to these reactions, with a focus on practical diagnostic tools. The effort will involve collecting blood and tissue samples from affected patients and testing biomarkers to create more accurate, faster classifications of reactions. The goal is to reduce unnecessary drug restrictions and improve safe treatment choices for patients experiencing these reactions.
Why it matters
Potential benefit: If successful, this work could lead to better and quicker diagnosis of non-IgE drug reactions, enabling safer use of antibiotics and other drugs.
How similar studies have gone: Prior work has established links between MRGRPX2-mediated pathways and certain drug reactions, with ongoing efforts to validate diagnostic biomarkers.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Alvarez Arango, Santiago — Ut Southwestern Medical Center
- Study coordinator: Alvarez Arango, Santiago
Related research
Other NIH-funded projects on the same topics.
-
Developing targeted therapies for Ewing sarcoma
This study is working on new treatments for Ewing sarcoma, a cancer that mainly affects kids and teens, by finding ways to target a specific protein that helps the cancer grow, so that we can offer safer and better options for those fighting this disease.
-
Neural roots of how autistic adults understand word meaning
A study to understand how adults with autism process word meanings in the brain, aiming to improve language support.
-
A new approach to healing NF1-related tibia fractures in children
This grant aims to understand why some NF1-related leg fractures in kids don’t heal well and to develop better treatments to help them recover without complications.
-
Multi-center study on how ventilation during CPR relates to cardiac arrest outcomes
A large, real-world study will look at how ventilation during CPR affects survival after out-of-hospital cardiac arrest in adults.
-
National Spina Bifida Patient Registry across the U.S.
A national registry collects health information from people with spina bifida to help doctors and families get better, more consistent care.
-
MONA-LISA: Understanding Why Autoimmune Signals Turn into Lupus Over Time
A study using data and samples from people with early autoimmune signs to understand why some develop full-blown lupus and others do not.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.